Navigation Links
Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
Date:5/19/2009

ll six assessment periods, including Week 72, in CAPACITY 2, and at all four of the assessment periods through Week 48 in CAPACITY 1, but not at Week 72. An analysis of pooled data from the two CAPACITY studies showed that placebo-treated patients experienced a mean of 76 mL more decline in FVC than patients who received pirfenidone at Week 72. At Week 48, patients who received pirfenidone experienced a mean of 169 mL less FVC decline compared to placebo in CAPACITY 2 (p=0.002) and a mean of 54 mL less FVC decline in CAPACITY 1 (p=0.006). This pattern of change is consistent with that observed at Week 52 in the Phase 3 study of pirfenidone conducted by Shionogi.

Categorical Analysis of Change in Six-Minute Walk Test (6MWT) Distance

Post-hoc analyses of data from the 826-patient INSPIRE trial suggested that patients experiencing a 50-meter decrement in distance walked during the 6MWT at six months had an approximately 2.5-fold increased risk in mortality. Using this threshold, 33% and 47% of pirfenidone and placebo patients, respectively, in CAPACITY 1 (p=0.013), and 37% and 47% of pirfenidone and placebo patients, respectively, in CAPACITY 2 (p=0.032) experienced this magnitude of change. In a pooled analysis, 35% and 47% of pirfenidone and placebo patients, respectively, experienced a change that exceeded this threshold (p=0.001).

Safety and Tolerability Results

Safety data presented for both studies showed that pirfenidone given as 2403 mg per day was safe and generally well tolerated. In CAPACITY 2, 83% and 90% of surviving, lung transplant-free patients completed therapy per protocol in the pirfenidone and placebo groups, respectively, and 82% and 90%, respectively, of patients did so in CAPACITY 1. The percentage of patients discontinuing treatment due to an adverse event across both studies combined was 15% and 9% in the pirfenidone and placebo groups, respectively.

'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

6

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
4. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
5. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
6. AlphaVax Announces Promising Results in Melanoma Studies
7. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
8. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
9. Bionovo Announces First Quarter 2009 Highlights and Financial Results
10. Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
11. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Daulton, CEO of Mammotome, a division of Devicor Medical Products, ... Cincinnati chapter of the Association for Corporate ... executive who is also a breast cancer survivor, led the ... of 2010. Daulton will be presented with the award at ... on May 22. The ACG Deal Maker Awards ...
(Date:5/21/2013)... , May 21, 2013 /PRNewswire-iReach/ -- The 2013 ... NJ has attracted the greatest number of "Emerging" ... President, Mark Alexay .  "No ... to attend this year.  The show,s still 4 months ... companies.  This is a big surprise and great ...
(Date:5/21/2013)... CLARA, Calif. , May 21, 2013 ... game-changing embedded-ultrasound platform, today announced the introduction ... that allows complete network-based communications with all ... its latest embedded-ultrasound technology, including this new ... Sao Paulo, Brazil from ...
Breaking Medicine Technology:Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 3Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2
... May 11 The DNA Medicine Institute announced today that ... the Bill & Melinda Gates Foundation.  The grant will support an innovative ... titled "Optomagnetic Finger Scanner for Malaria." , ... Dr. Chan,s project is one of 78 grants announced by ...
... CHANGCHUN, China and LOS ... Inc. (OTC Bulletin Board: CYXN) (the "Company" or,"China Yongxin"), one ... today,announced that on March 31st, 2010 , the Company,s ... as one of the,qualified pharmaceuticals distributors for Jilin ...
Cached Medicine Technology:DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 2DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 3China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province 2China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province 3
(Date:5/21/2013)... Calabash, NC (PRWEB) May 21, 2013 ... Lodges is synonymous with comprehensive travel guides. Brunswick Plantation ... play golf packages that include access to 27 holes ... available golf courses in North Carolina, knowing the ... Resorts and Lodges takes away the overwhelming task of ...
(Date:5/21/2013)... (PRWEB) May 22, 2013 About one ... the Fertility Clinics industry one of the ... assists patients who are unable to conceive naturally through ... popular of which is in-vitro fertilisation (IVF) cycles. Over ... cycles in Australia has increased by 4.4% per annum ...
(Date:5/21/2013)... Steven Reinberg HealthDay Reporter , , TUESDAY, May ... a major cause of sleep apnea in children, and ... learning for these kids, it did help them with ... finds. Sleep apnea is a condition that causes ... a greater improvement in sleep with the surgery, and ...
(Date:5/21/2013)... University of Iowa,s vice president for research and ... exascale computing, the next generation of supercomputers designed ... to the human mind. , Daniel Reed will ... of the House Subcommittee on Energy, titled, "America,s ... begins at 10 a.m. in Room 2318 of ...
(Date:5/21/2013)... Norton HealthDay Reporter , , TUESDAY, May 21 ... two genes may be at increased risk of suffering ... The researchers hope they can use the findings ... pregnant women who are vulnerable to postpartum depression, which ... study, reported in the May 21 issue of the ...
Breaking Medicine News(10 mins):Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Removing Tonsils Helps Kids With Sleep Apnea, Study Finds 2Health News:Removing Tonsils Helps Kids With Sleep Apnea, Study Finds 3Health News:Iowa VP for Research addresses next-generation supercomputers at congressional hearing 2Health News:Genes May Boost Woman's Risk of Postpartum Depression 2Health News:Genes May Boost Woman's Risk of Postpartum Depression 3
... FUND RESEARCH TO CURE CANCER IN ... DOGS - RESEARCH ALSO BENEFITING HUMANS, DENVER, Jan. 18 ... dogs and or very special humans in your life.,Morris Animal Foundation ... contributing $50 or more to the MAF canine,cancer cure research effort. ...
... LifeSync Corporation is,pleased to announce the appointment of ... McLane comes to LifeSync Corporation after,seven years at ... she,most recently held the position of Executive Director ... McLane spent over 13,years at C.R. Bard in ...
... by Christian Rocker and Top ,Clean, Comedian Round Out the All-Star ... ... 18 Our Savior Lutheran Church,announced today an all-star line-up for its ... Sure to satisfy all in,attendance, LoveFest offers its most diverse casting to ...
... dual implantation of radioactive seeds and chemotherapy wafers ... led by specialists at the Neuroscience Institute at ... , The study, published in the February issue ... treated with simultaneous implantation of radioactive seeds and ...
... are aimed at getting action from Cardinal George and Public Official ... ... 17 Three years ago, health care activist,Joe Novak -- during a ... end the abuses of not-for-profit health,care systems, especially those that are Catholic., ...
... Medical,Center has held extensive settlement discussions with the Public ... their apparent negotiating,tactic we remain optimistic that these discussions ... The filing of a lawsuit was unnecessary given the ... not receive any document outlining,Mr. Olvera,s specific claims until ...
Cached Medicine News:Health News:Unique Gift for Valentine's Day: Canine Cancer Campaign Customized Dog Tag - for Your Dog or as a Beautiful Piece of Jewelry for a Special Human 2Health News:LifeSync Corporation Appoints Nancy McLane as Senior Vice President Operations 2Health News:LoveFest 6 Taps Hollywood Actress to Headline Annual Abstinence Conference 2Health News:Combined radiation seed, chemotherapy wafer implants show promise in treating cancerous brain tumors 2Health News:Ad Campaign Targets Abuses by Not-For-Profits 2Health News:Hollywood Presbyterian Medical Center Responds to ACLU Lawsuit 2
... German Craftsmanship have produced ... in the world. Ocutek ... to you! Only holders ... certificate, which requires and ...
Protects the eye from symptoms caused by "dry eye, medical conditions, drug reactions and environmental factors. Forms a moisture chamber over the eye area during rest....
Protects the eye from symptoms caused by "dry eye, medical conditions, drug reactions and environmental factors. Forms a moisture chamber over the eye area during rest....
Protects the eye from symptoms caused by "dry eye, medical conditions, drug reactions and environmental factors. Forms a moisture chamber over the eye area during rest....
Medicine Products: